Paper20161378
Recent progress in protein drug design and discovery with a focus on novel approaches to the development of anti-cocaine medications.
Zheng F and 1 other. Future Med Chem, 2009. Cited by 27 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Recent progress in protein drug design and discovery with a focus on novel approaches to the development of anti-cocaine medications. Papers, record 20161378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20161378
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent progress in protein drug design and discovery with a focus on novel approaches to the development of anti-cocaine medications.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cocaine | Major topic |
| Binding Sites | |
| Butyrylcholinesterase | |
| Carboxylic Ester Hydrolases | |
| Computer Simulation | |
| Drug Design | |
| Drug Evaluation, Preclinical | |
| Humans |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DA013930 | NIDA NIH HHS | United States | R01DA013930 | PubMed and NIH | NIH RePORTER |
| R01 DA021416 | NIDA NIH HHS | United States | R01DA021416 | PubMed and NIH | NIH RePORTER |
| R01 DA025100 | NIDA NIH HHS | United States | R01DA025100 | PubMed and NIH | NIH RePORTER |
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,880,781 | First-principle studies of intermolecular and intramolecular catalysis of protonated cocaine. | J Comput Chem | 2005 | https://conductscience.org/library/papers/15880781 | PubMed |
| 2 | 19,254,552 | Free-energy perturbation simulation on transition states and redesign of butyrylcholinesterase. | Biophys J | 2009 | https://conductscience.org/library/papers/19254552 | PubMed |
| 3 | 18,568,020 | The binding sites for cocaine and dopamine in the dopamine transporter overlap. | Nat Neurosci | 2008 | https://conductscience.org/library/papers/18568020 | PubMed |
| 4 | 16,319,079 | Catalytic mechanism and energy barriers for butyrylcholinesterase-catalyzed hydrolysis of cocaine. | Biophys J | 2005 | https://conductscience.org/library/papers/16319079 | PubMed |
| 5 | 12,948,494 | A large scale test of computational protein design: folding and stability of nine completely redesigned globular proteins. | J Mol Biol | 2003 | https://conductscience.org/library/papers/12948494 | PubMed |
| 6 | 12,603,134 | Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase. | J Am Chem Soc | 2003 | https://conductscience.org/library/papers/12603134 | PubMed |
| 7 | 9,449,014 | Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. | Drug Alcohol Depend | 1997 | https://conductscience.org/library/papers/9449014 | PubMed |
| 8 | 16,851,561 | Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants. | J Phys Chem B | 2005 | https://conductscience.org/library/papers/16851561 | PubMed |
| 9 | 17,551,070 | Cocaine use and stroke. | Postgrad Med J | 2007 | https://conductscience.org/library/papers/17551070 | PubMed |
| 10 | 18,323,453 | De novo computational design of retro-aldol enzymes. | Science | 2008 | https://conductscience.org/library/papers/18323453 | PubMed |
| 11 | 16,968,810 | Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. | Mol Pharmacol | 2006 | https://conductscience.org/library/papers/16968810 | PubMed |
| 12 | 16,275,916 | Computational redesign of human butyrylcholinesterase for anticocaine medication. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16275916 | PubMed |
| 13 | 17,335,299 | Agalsidase Beta: a review of its use in the management of Fabry disease. | Drugs | 2007 | https://conductscience.org/library/papers/17335299 | PubMed |
| 14 | 18,485,214 | Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin. | BMC Biotechnol | 2008 | https://conductscience.org/library/papers/18485214 | PubMed |
| 15 | 9,243,335 | Anti-cocaine catalytic antibodies--a novel approach to the problem of addiction. | J Addict Dis | 1997 | https://conductscience.org/library/papers/9243335 | PubMed |
| 16 | 15,233,592 | Agents in development for the management of cocaine abuse. | Drugs | 2004 | https://conductscience.org/library/papers/15233592 | PubMed |
| 17 | 11,533,486 | Design of bioelectronic interfaces by exploiting hinge-bending motions in proteins. | Science | 2001 | https://conductscience.org/library/papers/11533486 | PubMed |
| 18 | 18,199,998 | A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. | Neuropsychopharmacology | 2008 | https://conductscience.org/library/papers/18199998 | PubMed |
| 19 | 17,114,567 | Cocaine esterase: interactions with cocaine and immune responses in mice. | J Pharmacol Exp Ther | 2007 | https://conductscience.org/library/papers/17114567 | PubMed |
| 20 | 18,341,277 | Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers. | J Am Chem Soc | 2008 | https://conductscience.org/library/papers/18341277 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,740,850 | In vitro and in vivo stability of a highly efficient long-acting cocaine hydrolase. | Sci Rep | 2024 | https://conductscience.org/library/papers/38740850 | PubMed |
| 38,195,724 | Long-lasting blocking of interoceptive effects of cocaine by a highly efficient cocaine hydrolase in rats. | Sci Rep | 2024 | https://conductscience.org/library/papers/38195724 | PubMed |
| 36,301,205 | Gender differences in cocaine-induced hyperactivity and dopamine transporter trafficking to the plasma membrane. | Addict Biol | 2022 | https://conductscience.org/library/papers/36301205 | PubMed |
| 35,754,103 | Recovery of dopaminergic system after cocaine exposure and impact of a long-acting cocaine hydrolase. | Addict Biol | 2022 | https://conductscience.org/library/papers/35754103 | PubMed |
| 34,363,291 | Cocaine hydrolase blocks cocaine-induced dopamine transporter trafficking to the plasma membrane. | Addict Biol | 2022 | https://conductscience.org/library/papers/34363291 | PubMed |
| 32,710,979 | Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: Long-lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine. | Neuropharmacology | 2020 | https://conductscience.org/library/papers/32710979 | PubMed |
| 32,389,751 | Cebranopadol reduces cocaine self-administration in male rats: Dose, treatment and safety consideration. | Neuropharmacology | 2020 | https://conductscience.org/library/papers/32389751 | PubMed |
| 32,189,158 | Structure-Based Design and Discovery of a Long-Acting Cocaine Hydrolase Mutant with Improved Binding Affinity to Neonatal Fc Receptor for Treatment of Cocaine Abuse. | AAPS J | 2020 | https://conductscience.org/library/papers/32189158 | PubMed |
| 31,661,952 | PEGylation but Not Fc-Fusion Improves in Vivo Residence Time of a Thermostable Mutant of Bacterial Cocaine Esterase. | Bioconjug Chem | 2019 | https://conductscience.org/library/papers/31661952 | PubMed |
| 30,095,924 | Catalytic Reaction Mechanism for Drug Metabolism in Human Carboxylesterase-1: Cocaine Hydrolysis Pathway. | Mol Pharm | 2018 | https://conductscience.org/library/papers/30095924 | PubMed |
| 29,556,863 | Development of Fc-Fused Cocaine Hydrolase for Cocaine Addiction Treatment: Catalytic and Pharmacokinetic Properties. | AAPS J | 2018 | https://conductscience.org/library/papers/29556863 | PubMed |
| 28,255,755 | Epigenetics: a link between addiction and social environment. | Cell Mol Life Sci | 2017 | https://conductscience.org/library/papers/28255755 | PubMed |
| 25,321,637 | Butyrylcholinesterase levels and subjective effects of smoked cocaine in healthy cocaine users. | Am J Drug Alcohol Abuse | 2015 | https://conductscience.org/library/papers/25321637 | PubMed |
| 24,290,065 | Modeling in vitro inhibition of butyrylcholinesterase using molecular docking, multi-linear regression and artificial neural network approaches. | Bioorg Med Chem | 2014 | https://conductscience.org/library/papers/24290065 | PubMed |
| 23,849,058 | Preparation and in vivo characterization of a cocaine hydrolase engineered from human butyrylcholinesterase for metabolizing cocaine. | Biochem J | 2013 | https://conductscience.org/library/papers/23849058 | PubMed |
| 22,917,637 | Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine. | Chem Biol Interact | 2013 | https://conductscience.org/library/papers/22917637 | PubMed |
| 22,844,238 | Modeling of pharmacokinetics of cocaine in human reveals the feasibility for development of enzyme therapies for drugs of abuse. | PLoS Comput Biol | 2012 | https://conductscience.org/library/papers/22844238 | PubMed |
| 21,428,822 | Enzyme-therapy approaches for the treatment of drug overdose and addiction. | Future Med Chem | 2011 | https://conductscience.org/library/papers/21428822 | PubMed |
| 20,886,866 | Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency. | Biochemistry | 2010 | https://conductscience.org/library/papers/20886866 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCHE | 590 | PubTator's text mining | https://conductscience.org/library/genes/590 | NCBI Gene |
| CES1 | 1,066 | PubTator's text mining | https://conductscience.org/library/genes/1066 | NCBI Gene |
| CES2 | 8,824 | PubTator's text mining | https://conductscience.org/library/genes/8824 | NCBI Gene |
| CYP4F3 | 4,051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
| SLC6A3 | 6,531 | PubTator's text mining | https://conductscience.org/library/genes/6531 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20161378
GET https://conductscience.org/api/papers/v1/20161378/references?page=2